Alain Litwin, , MD, MPH, MS
Dr. Litwin is board certified in internal medicine and addiction medicine. He has been providing medical care to drug users with complex social, psychiatric and medical needs within an integrated primary care and methadone maintenance treatment program for over 17 years. He has received numerous funding including from NIDA, PCORI, CDC, SAMHSA, AHRQ, CMS, Robert Wood Johnson Foundation, and local and state government.
Dr. Litwin is the PI of PCORI-funded national, multi-site HCV randomized controlled trial focused on improving HCV outcomes in people who inject drugs (8 states and 26 sites).
Dr. Litwin is an international leader in implementing and studying interventions for people who use drugs in heterogeneous settings while incorporating stakeholder input. He has served as the Medical Director of a large methadone maintenance treatment program and is currently Medical Director of an integrated addiction treatment program.